✦ LIBER ✦
187 POSTER A phase II study of daily gefitinib plus weekly paclitaxel (GP) in Taiwanese non-small cell lung cancer (NSCLC) patients who failed prior gefitinib or both gefitinib and taxane treatment
✍ Scribed by C. Tsai; C. Chiu; C. Lai; J. Liu; R. Perng
- Book ID
- 118623815
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 53 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.